Hemoglobinopathies (structural defects in hemoglobin)

TR Randolph - … hematology: clinical principles and application. St …, 2019 - books.google.com
1. Explain the difference between structural hemoglobin disorders and thalassemias, and
describe the types of mutations found in the structural disorders. 2. Describe globin gene …

Chronic myelocytic leukemia–Part I: History, clinical presentation, and molecular biology

TR Randolph - American Society for Clinical Laboratory Science, 2005 - clsjournal.ascls.org
DATA SOURCES: Current literature. DATA SYNTHESIS: Chronic myelocytic leukemia (CML)
was initially described in 1845 and is considered one of the first leukemias to be discovered…

Acute promyelocytic leukemia (AML-M3)-part 1: Pathophysiology, clinical diagnosis, and differentiation therapy

TR Randolph - Clinical Laboratory Science, 2000 - search.proquest.com
The objectives of this review paper are to: Compare acute leukemia with chronic leukemia
and other forms of cancer. Review the pathophysiology and discuss the clinical and …

Advances in acute lymphoblastic leukemia

TR Randolph - American Society for Clinical Laboratory Science, 2004 - clsjournal.ascls.org
DATA SOURCES: Current literature DATA SYNTHESIS: Acute lymphoblastic leukemia (ALL)
is a stem cell disorder characterized by an overproduction of lymphoblasts in the bone …

Novel test method (sickle confirm) to differentiate sickle cell anemia from sickle cell trait for potential use in developing countries

TR Randolph, J Wheelhouse - American Society for Clinical …, 2012 - clsjournal.ascls.org
The objective of this study was to develop a diagnostic testing method to detect HbS, distinguish
sickle cell homozygotes from heterozygotes, and overcome testing barriers encountered …

Estimated prevalence of sickle cell in northern Haiti

TR Randolph - American Society for Clinical Laboratory Science, 2010 - clsjournal.ascls.org
OBJECTIVE: The purpose of this study is to estimate the prevalence of sickle hemoglobin in
northern Haiti. DESIGN: Sickle cell testing occurred from 2002-2009. Blood samples from …

Chronic myelocytic leukemia–part II: approaches to and molecular monitoring of therapy

TR Randolph - American Society for Clinical Laboratory Science, 2005 - clsjournal.ascls.org
DATA SOURCES: Current literature. DATA SYNTHESIS: Chronic myelocytic leukemia (CML)
was initially described in 1845 and is considered one of the first leukemias discovered. …

[PDF][PDF] Pathophysiology of compound heterozygotes involving hemoglobinopathies and thalassemias

TR Randolph - Clinical Laboratory Science, 2008 - clsjournal.ascls.org
TIM R RANDOLPHTim R Randolph PhD MT(ASCP) CLS(NCA) is associate … Address for
Correspondence:Tim R Randolph MS MT(ASCP) CLS(NCA), associate professor, Department …

Acute promyelocytic leukemia (AML-M3)-part 2: molecular defect, DNA diagnosis, and proposed models of leukemogenesis and differentiation therapy

TR Randolph - Clinical Laboratory Science, 2000 - search.proquest.com
To identify the chromosomal translocation common in M3 and discuss its diagnostic use to:
Compare acute leukemia with chronic leukemia and other forms of cancer. Describe the …

Development of a micro-ESR system with potential for in-home use

SE Douglas, TR Randolph - American Society for Clinical …, 2007 - clsjournal.ascls.org
OBJECTIVE: To develop a micro-erythrocyte sedimentation rate (ESR) system with potential
to be self-administered by patients at home using capillary blood. DESIGN: For each subject…